Apabetalone as a cancer drug?

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Apabetalone as a cancer drug?

posted on May 29, 2019 10:45AM

The anti-IL-1β antibody canakinumab in CANTOS was designed to test the inflammation hypothesis in cardiovascular disease but also found benefit in lung cancer. Dr. Paul Ridker, lead CANTOS investigator, discusses "Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation."

https://pace-cme.org/2019/05/28/effect-of-il-1-inhibition-on-lung-cancer-sheds-new-light-on-the-role-of-inflammation/

Apabetalone has potent anti-inflammatory effects. What kind of surprises might apabetalone have in store beyond cardiovascular, renal and cognition? Apabetalone as a cancer drug? No proof yet, but BETonMACE full data will be interesting to see!